Lilly to Launch Online Medicine-Making Class

Lilly completed the CoLucid acquisition in March.

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has created a course designed to help students who have an interest in health care and medical research to better understand the process involved in drug discovery and development.

Lilly says it is collaborating with 10 leaders from academic institutions to form the elective graduate-level "Making Medicines" course. The pharmaceutical company is getting ready to unveil the e-learning course at the American Osteopathic Association scientific conference in Orlando.

Lilly Director of External Relations for U.S. Medical Affairs Yolanda Johnson-Moton says the online course will teach students about the process of bringing a drug to market and the regulatory environment that govern the biopharmaceutical industry.

"We identified a knowledge gap surrounding the biopharmaceutical industry and its drug discovery and development process, and set out to find a solution that would further education and awareness. Our unified focus is on creating better patient outcomes, and the healthcare providers of tomorrow are an integral part of the process," Johnson-Moton said.

Johnson-Moton says the course will be available in early 2016 at universities across the country.